<?xml version="1.0" encoding="utf-8"?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="2007-10-02" modified="2020-10-07" version="150">
<accession>O94992</accession>
<accession>B2R8Y5</accession>
<name>HEXI1_HUMAN</name>
<protein>
<recommendedName>
<fullName>Protein HEXIM1</fullName>
</recommendedName>
<alternativeName>
<fullName>Cardiac lineage protein 1</fullName>
</alternativeName>
<alternativeName>
<fullName>Estrogen down-regulated gene 1 protein</fullName>
</alternativeName>
<alternativeName>
<fullName>Hexamethylene bis-acetamide-inducible protein 1</fullName>
</alternativeName>
<alternativeName>
<fullName>Menage a quatre protein 1</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary">HEXIM1</name>
<name type="synonym">CLP1</name>
<name type="synonym">EDG1</name>
<name type="synonym">HIS1</name>
<name type="synonym">MAQ1</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1999" name="Biomed. Res." volume="20" first="273" last="279">
<title>Cloning of hexamethylene-bis-acetamide-inducible transcript, HEXIM1, in human vascular smooth muscle cells.</title>
<authorList>
<person name="Kusuhara M."/>
<person name="Nagasaki K."/>
<person name="Kimura K."/>
<person name="Maass N."/>
<person name="Manabe T."/>
<person name="Ishikawa S."/>
<person name="Aikawa M."/>
<person name="Miyazaki K."/>
<person name="Yamaguchi K."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<source>
<tissue>Vascular smooth muscle</tissue>
</source>
</reference>
<reference key="2">
<citation type="journal article" date="2004" name="Nat. Genet." volume="36" first="40" last="45">
<title>Complete sequencing and characterization of 21,243 full-length human cDNAs.</title>
<authorList>
<person name="Ota T."/>
<person name="Suzuki Y."/>
<person name="Nishikawa T."/>
<person name="Otsuki T."/>
<person name="Sugiyama T."/>
<person name="Irie R."/>
<person name="Wakamatsu A."/>
<person name="Hayashi K."/>
<person name="Sato H."/>
<person name="Nagai K."/>
<person name="Kimura K."/>
<person name="Makita H."/>
<person name="Sekine M."/>
<person name="Obayashi M."/>
<person name="Nishi T."/>
<person name="Shibahara T."/>
<person name="Tanaka T."/>
<person name="Ishii S."/>
<person name="Yamamoto J."/>
<person name="Saito K."/>
<person name="Kawai Y."/>
<person name="Isono Y."/>
<person name="Nakamura Y."/>
<person name="Nagahari K."/>
<person name="Murakami K."/>
<person name="Yasuda T."/>
<person name="Iwayanagi T."/>
<person name="Wagatsuma M."/>
<person name="Shiratori A."/>
<person name="Sudo H."/>
<person name="Hosoiri T."/>
<person name="Kaku Y."/>
<person name="Kodaira H."/>
<person name="Kondo H."/>
<person name="Sugawara M."/>
<person name="Takahashi M."/>
<person name="Kanda K."/>
<person name="Yokoi T."/>
<person name="Furuya T."/>
<person name="Kikkawa E."/>
<person name="Omura Y."/>
<person name="Abe K."/>
<person name="Kamihara K."/>
<person name="Katsuta N."/>
<person name="Sato K."/>
<person name="Tanikawa M."/>
<person name="Yamazaki M."/>
<person name="Ninomiya K."/>
<person name="Ishibashi T."/>
<person name="Yamashita H."/>
<person name="Murakawa K."/>
<person name="Fujimori K."/>
<person name="Tanai H."/>
<person name="Kimata M."/>
<person name="Watanabe M."/>
<person name="Hiraoka S."/>
<person name="Chiba Y."/>
<person name="Ishida S."/>
<person name="Ono Y."/>
<person name="Takiguchi S."/>
<person name="Watanabe S."/>
<person name="Yosida M."/>
<person name="Hotuta T."/>
<person name="Kusano J."/>
<person name="Kanehori K."/>
<person name="Takahashi-Fujii A."/>
<person name="Hara H."/>
<person name="Tanase T.-O."/>
<person name="Nomura Y."/>
<person name="Togiya S."/>
<person name="Komai F."/>
<person name="Hara R."/>
<person name="Takeuchi K."/>
<person name="Arita M."/>
<person name="Imose N."/>
<person name="Musashino K."/>
<person name="Yuuki H."/>
<person name="Oshima A."/>
<person name="Sasaki N."/>
<person name="Aotsuka S."/>
<person name="Yoshikawa Y."/>
<person name="Matsunawa H."/>
<person name="Ichihara T."/>
<person name="Shiohata N."/>
<person name="Sano S."/>
<person name="Moriya S."/>
<person name="Momiyama H."/>
<person name="Satoh N."/>
<person name="Takami S."/>
<person name="Terashima Y."/>
<person name="Suzuki O."/>
<person name="Nakagawa S."/>
<person name="Senoh A."/>
<person name="Mizoguchi H."/>
<person name="Goto Y."/>
<person name="Shimizu F."/>
<person name="Wakebe H."/>
<person name="Hishigaki H."/>
<person name="Watanabe T."/>
<person name="Sugiyama A."/>
<person name="Takemoto M."/>
<person name="Kawakami B."/>
<person name="Yamazaki M."/>
<person name="Watanabe K."/>
<person name="Kumagai A."/>
<person name="Itakura S."/>
<person name="Fukuzumi Y."/>
<person name="Fujimori Y."/>
<person name="Komiyama M."/>
<person name="Tashiro H."/>
<person name="Tanigami A."/>
<person name="Fujiwara T."/>
<person name="Ono T."/>
<person name="Yamada K."/>
<person name="Fujii Y."/>
<person name="Ozaki K."/>
<person name="Hirao M."/>
<person name="Ohmori Y."/>
<person name="Kawabata A."/>
<person name="Hikiji T."/>
<person name="Kobatake N."/>
<person name="Inagaki H."/>
<person name="Ikema Y."/>
<person name="Okamoto S."/>
<person name="Okitani R."/>
<person name="Kawakami T."/>
<person name="Noguchi S."/>
<person name="Itoh T."/>
<person name="Shigeta K."/>
<person name="Senba T."/>
<person name="Matsumura K."/>
<person name="Nakajima Y."/>
<person name="Mizuno T."/>
<person name="Morinaga M."/>
<person name="Sasaki M."/>
<person name="Togashi T."/>
<person name="Oyama M."/>
<person name="Hata H."/>
<person name="Watanabe M."/>
<person name="Komatsu T."/>
<person name="Mizushima-Sugano J."/>
<person name="Satoh T."/>
<person name="Shirai Y."/>
<person name="Takahashi Y."/>
<person name="Nakagawa K."/>
<person name="Okumura K."/>
<person name="Nagase T."/>
<person name="Nomura N."/>
<person name="Kikuchi H."/>
<person name="Masuho Y."/>
<person name="Yamashita R."/>
<person name="Nakai K."/>
<person name="Yada T."/>
<person name="Nakamura Y."/>
<person name="Ohara O."/>
<person name="Isogai T."/>
<person name="Sugano S."/>
</authorList>
<dbReference type="PubMed" id="14702039"/>
<dbReference type="DOI" id="10.1038/ng1285"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
<source>
<tissue>Pericardium</tissue>
</source>
</reference>
<reference key="3">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
<source>
<tissue>Lung</tissue>
</source>
</reference>
<reference key="4">
<citation type="journal article" date="2003" name="Cancer Res." volume="63" first="5151" last="5158">
<title>Identification of a novel inhibitor of breast cell growth that is down-regulated by estrogens and decreased in breast tumors.</title>
<authorList>
<person name="Wittmann B.M."/>
<person name="Wang N."/>
<person name="Montano M.M."/>
</authorList>
<dbReference type="PubMed" id="12941847"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
<scope>TISSUE SPECIFICITY</scope>
<scope>INDUCTION BY ESTROGEN</scope>
</reference>
<reference key="5">
<citation type="journal article" date="2003" name="Genes Cells" volume="8" first="95" last="107">
<title>Suppression of NF-kappaB-dependent gene expression by a hexamethylene bisacetamide-inducible protein HEXIM1 in human vascular smooth muscle cells.</title>
<authorList>
<person name="Ouchida R."/>
<person name="Kusuhara M."/>
<person name="Shimizu N."/>
<person name="Hisada T."/>
<person name="Makino Y."/>
<person name="Morimoto C."/>
<person name="Handa H."/>
<person name="Ohsuzu F."/>
<person name="Tanaka H."/>
</authorList>
<dbReference type="PubMed" id="12581153"/>
<dbReference type="DOI" id="10.1046/j.1365-2443.2003.00618.x"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH RELA</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>INDUCTION BY HMBA</scope>
</reference>
<reference key="6">
<citation type="journal article" date="2003" name="Mol. Cell" volume="12" first="971" last="982">
<title>Inhibition of P-TEFb (CDK9/Cyclin T) kinase and RNA polymerase II transcription by the coordinated actions of HEXIM1 and 7SK snRNA.</title>
<authorList>
<person name="Yik J.H.N."/>
<person name="Chen R."/>
<person name="Nishimura R."/>
<person name="Jennings J.L."/>
<person name="Link A.J."/>
<person name="Zhou Q."/>
</authorList>
<dbReference type="PubMed" id="14580347"/>
<dbReference type="DOI" id="10.1016/s1097-2765(03)00388-5"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="7">
<citation type="journal article" date="2003" name="Mol. Cell. Biol." volume="23" first="4859" last="4869">
<title>MAQ1 and 7SK RNA interact with CDK9/cyclin T complexes in a transcription-dependent manner.</title>
<authorList>
<person name="Michels A.A."/>
<person name="Nguyen V.T."/>
<person name="Fraldi A."/>
<person name="Labas V."/>
<person name="Edwards M."/>
<person name="Bonnet F."/>
<person name="Lania L."/>
<person name="Bensaude O."/>
</authorList>
<dbReference type="PubMed" id="12832472"/>
<dbReference type="DOI" id="10.1128/mcb.23.14.4859-4869.2003"/>
</citation>
<scope>FUNCTION</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
<scope>IDENTIFICATION IN THE 7SK RNP COMPLEX</scope>
<scope>INTERACTION WITH CCNT1</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="8">
<citation type="journal article" date="2004" name="EMBO J." volume="23" first="2608" last="2619">
<title>Binding of the 7SK snRNA turns the HEXIM1 protein into a P-TEFb (CDK9/cyclin T) inhibitor.</title>
<authorList>
<person name="Michels A.A."/>
<person name="Fraldi A."/>
<person name="Li Q."/>
<person name="Adamson T.E."/>
<person name="Bonnet F."/>
<person name="Nguyen V.T."/>
<person name="Sedore S.C."/>
<person name="Price J.P."/>
<person name="Price D.H."/>
<person name="Lania L."/>
<person name="Bensaude O."/>
</authorList>
<dbReference type="PubMed" id="15201869"/>
<dbReference type="DOI" id="10.1038/sj.emboj.7600275"/>
</citation>
<scope>FUNCTION</scope>
<scope>MUTAGENESIS OF 152-LYS--ARG-155; TYR-203 AND THR-205</scope>
<scope>INTERACTION WITH P-TEFB</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2004" name="Mol. Cell. Biol." volume="24" first="5094" last="5105">
<title>A human immunodeficiency virus type 1 Tat-like arginine-rich RNA-binding domain is essential for HEXIM1 to inhibit RNA polymerase II transcription through 7SK snRNA-mediated inactivation of P-TEFb.</title>
<authorList>
<person name="Yik J.H.N."/>
<person name="Chen R."/>
<person name="Pezda A.C."/>
<person name="Samford C.S."/>
<person name="Zhou Q."/>
</authorList>
<dbReference type="PubMed" id="15169877"/>
<dbReference type="DOI" id="10.1128/mcb.24.12.5094-5105.2004"/>
</citation>
<scope>INTERACTION WITH P-TEFB</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2005" name="EMBO J." volume="24" first="4291" last="4303">
<title>Interplay between 7SK snRNA and oppositely charged regions in HEXIM1 direct the inhibition of P-TEFb.</title>
<authorList>
<person name="Barboric M."/>
<person name="Kohoutek J."/>
<person name="Price J.P."/>
<person name="Blazek D."/>
<person name="Price D.H."/>
<person name="Peterlin B.M."/>
</authorList>
<dbReference type="PubMed" id="16362050"/>
<dbReference type="DOI" id="10.1038/sj.emboj.7600883"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
<scope>INTERACTION WITH THE 7SK SNRNA AND P-TEFB</scope>
<scope>MUTAGENESIS OF 154-ARG--ARG-156</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2005" name="J. Biol. Chem." volume="280" first="16368" last="16376">
<title>Compensatory contributions of HEXIM1 and HEXIM2 in maintaining the balance of active and inactive positive transcription elongation factor b complexes for control of transcription.</title>
<authorList>
<person name="Yik J.H.N."/>
<person name="Chen R."/>
<person name="Pezda A.C."/>
<person name="Zhou Q."/>
</authorList>
<dbReference type="PubMed" id="15713661"/>
<dbReference type="DOI" id="10.1074/jbc.m500912200"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH HEXIM2</scope>
<scope>OLIGOMERIZATION</scope>
<scope>TISSUE SPECIFICITY</scope>
<scope>INDUCTION</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2005" name="J. Biol. Chem." volume="280" first="24968" last="24977">
<title>Identification of a cyclin T-binding domain in Hexim1 and biochemical analysis of its binding competition with HIV-1 Tat.</title>
<authorList>
<person name="Schulte A."/>
<person name="Czudnochowski N."/>
<person name="Barboric M."/>
<person name="Schoenichen A."/>
<person name="Blazek D."/>
<person name="Peterlin B.M."/>
<person name="Geyer M."/>
</authorList>
<dbReference type="PubMed" id="15855166"/>
<dbReference type="DOI" id="10.1074/jbc.m501431200"/>
</citation>
<scope>INTERACTION WITH CCNT1</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2005" name="J. Biol. Chem." volume="280" first="28819" last="28826">
<title>Analysis of the large inactive P-TEFb complex indicates that it contains one 7SK molecule, a dimer of HEXIM1 or HEXIM2, and two P-TEFb molecules containing Cdk9 phosphorylated at threonine 186.</title>
<authorList>
<person name="Li Q."/>
<person name="Price J.P."/>
<person name="Byers S.A."/>
<person name="Cheng D."/>
<person name="Peng J."/>
<person name="Price D.H."/>
</authorList>
<dbReference type="PubMed" id="15965233"/>
<dbReference type="DOI" id="10.1074/jbc.m502712200"/>
</citation>
<scope>OLIGOMERIZATION</scope>
<scope>MUTAGENESIS OF PHE-208 AND TYR-271</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2005" name="Nucleic Acids Res." volume="33" first="7000" last="7010">
<title>Oligomerization of HEXIM1 via 7SK snRNA and coiled-coil region directs the inhibition of P-TEFb.</title>
<authorList>
<person name="Blazek D."/>
<person name="Barboric M."/>
<person name="Kohoutek J."/>
<person name="Oven I."/>
<person name="Peterlin B.M."/>
</authorList>
<dbReference type="PubMed" id="16377779"/>
<dbReference type="DOI" id="10.1093/nar/gki997"/>
</citation>
<scope>INTERACTION WITH P-TEFB</scope>
<scope>OLIGOMERIZATION</scope>
<scope>MUTAGENESIS OF LEU-287; LEU-294; LEU-332 AND LEU-339</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2005" name="Oncogene" volume="24" first="5576" last="5588">
<title>The breast cell growth inhibitor, estrogen down regulated gene 1, modulates a novel functional interaction between estrogen receptor alpha and transcriptional elongation factor cyclin T1.</title>
<authorList>
<person name="Wittmann B.M."/>
<person name="Fujinaga K."/>
<person name="Deng H."/>
<person name="Ogba N."/>
<person name="Montano M.M."/>
</authorList>
<dbReference type="PubMed" id="15940264"/>
<dbReference type="DOI" id="10.1038/sj.onc.1208728"/>
</citation>
<scope>FUNCTION IN ESR1-DEPENDENT TRANSCRIPTION</scope>
<scope>INTERACTION WITH ESR1</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2005" name="Proc. Natl. Acad. Sci. U.S.A." volume="102" first="8555" last="8560">
<title>HEXIM1 forms a transcriptionally abortive complex with glucocorticoid receptor without involving 7SK RNA and positive transcription elongation factor b.</title>
<authorList>
<person name="Shimizu N."/>
<person name="Ouchida R."/>
<person name="Yoshikawa N."/>
<person name="Hisada T."/>
<person name="Watanabe H."/>
<person name="Okamoto K."/>
<person name="Kusuhara M."/>
<person name="Handa H."/>
<person name="Morimoto C."/>
<person name="Tanaka H."/>
</authorList>
<dbReference type="PubMed" id="15941832"/>
<dbReference type="DOI" id="10.1073/pnas.0409863102"/>
</citation>
<scope>FUNCTION IN NR3C1-DEPENDENT TRANSCRIPTION</scope>
<scope>INTERACTION WITH NR3C1</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2006" name="Proc. Natl. Acad. Sci. U.S.A." volume="103" first="17349" last="17354">
<title>Hexim1 sequesters positive transcription elongation factor b from the class II transactivator on MHC class II promoters.</title>
<authorList>
<person name="Kohoutek J."/>
<person name="Blazek D."/>
<person name="Peterlin B.M."/>
</authorList>
<dbReference type="PubMed" id="17088550"/>
<dbReference type="DOI" id="10.1073/pnas.0603079103"/>
</citation>
<scope>FUNCTION IN CIITA-DEPENDENT TRANSCRIPTION</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2007" name="Mol. Cell" volume="27" first="262" last="274">
<title>Systematic analysis of the protein interaction network for the human transcription machinery reveals the identity of the 7SK capping enzyme.</title>
<authorList>
<person name="Jeronimo C."/>
<person name="Forget D."/>
<person name="Bouchard A."/>
<person name="Li Q."/>
<person name="Chua G."/>
<person name="Poitras C."/>
<person name="Therien C."/>
<person name="Bergeron D."/>
<person name="Bourassa S."/>
<person name="Greenblatt J."/>
<person name="Chabot B."/>
<person name="Poirier G.G."/>
<person name="Hughes T.R."/>
<person name="Blanchette M."/>
<person name="Price D.H."/>
<person name="Coulombe B."/>
</authorList>
<dbReference type="PubMed" id="17643375"/>
<dbReference type="DOI" id="10.1016/j.molcel.2007.06.027"/>
</citation>
<scope>IDENTIFICATION IN THE 7SK RNP COMPLEX</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2007" name="Mol. Cell. Biol." volume="27" first="4641" last="4651">
<title>Regulation of P-TEFb elongation complex activity by CDK9 acetylation.</title>
<authorList>
<person name="Fu J."/>
<person name="Yoon H.-G."/>
<person name="Qin J."/>
<person name="Wong J."/>
</authorList>
<dbReference type="PubMed" id="17452463"/>
<dbReference type="DOI" id="10.1128/mcb.00857-06"/>
</citation>
<scope>INTERACTION WITH NCOR1</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2007" name="Nucleic Acids Res." volume="35" first="2503" last="2512">
<title>HEXIM1 is a promiscuous double-stranded RNA-binding protein and interacts with RNAs in addition to 7SK in cultured cells.</title>
<authorList>
<person name="Li Q."/>
<person name="Cooper J.J."/>
<person name="Altwerger G.H."/>
<person name="Feldkamp M.D."/>
<person name="Shea M.A."/>
<person name="Price D.H."/>
</authorList>
<dbReference type="PubMed" id="17395637"/>
<dbReference type="DOI" id="10.1093/nar/gkm150"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2008" name="Proc. Natl. Acad. Sci. U.S.A." volume="105" first="10762" last="10767">
<title>A quantitative atlas of mitotic phosphorylation.</title>
<authorList>
<person name="Dephoure N."/>
<person name="Zhou C."/>
<person name="Villen J."/>
<person name="Beausoleil S.A."/>
<person name="Bakalarski C.E."/>
<person name="Elledge S.J."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="18669648"/>
<dbReference type="DOI" id="10.1073/pnas.0805139105"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-97; SER-98; SER-233; THR-236; SER-237 AND SER-252</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="22">
<citation type="journal article" date="2009" name="Sci. Signal." volume="2" first="RA46" last="RA46">
<title>Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions.</title>
<authorList>
<person name="Mayya V."/>
<person name="Lundgren D.H."/>
<person name="Hwang S.-I."/>
<person name="Rezaul K."/>
<person name="Wu L."/>
<person name="Eng J.K."/>
<person name="Rodionov V."/>
<person name="Han D.K."/>
</authorList>
<dbReference type="PubMed" id="19690332"/>
<dbReference type="DOI" id="10.1126/scisignal.2000007"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-233; THR-236; SER-237 AND SER-252</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Leukemic T-cell</tissue>
</source>
</reference>
<reference key="23">
<citation type="journal article" date="2010" name="J. Mol. Biol." volume="395" first="28" last="41">
<title>Specificity of Hexim1 and Hexim2 complex formation with cyclin T1/T2, importin alpha and 7SK snRNA.</title>
<authorList>
<person name="Czudnochowski N."/>
<person name="Vollmuth F."/>
<person name="Baumann S."/>
<person name="Vogel-Bachmayr K."/>
<person name="Geyer M."/>
</authorList>
<dbReference type="PubMed" id="19883659"/>
<dbReference type="DOI" id="10.1016/j.jmb.2009.10.055"/>
</citation>
<scope>INTERACTION WITH CCNT2</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2010" name="Sci. Signal." volume="3" first="RA3" last="RA3">
<title>Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Vermeulen M."/>
<person name="Santamaria A."/>
<person name="Kumar C."/>
<person name="Miller M.L."/>
<person name="Jensen L.J."/>
<person name="Gnad F."/>
<person name="Cox J."/>
<person name="Jensen T.S."/>
<person name="Nigg E.A."/>
<person name="Brunak S."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="20068231"/>
<dbReference type="DOI" id="10.1126/scisignal.2000475"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-233; THR-236; SER-237 AND SER-252</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="25">
<citation type="journal article" date="2011" name="BMC Syst. Biol." volume="5" first="17" last="17">
<title>Initial characterization of the human central proteome.</title>
<authorList>
<person name="Burkard T.R."/>
<person name="Planyavsky M."/>
<person name="Kaupe I."/>
<person name="Breitwieser F.P."/>
<person name="Buerckstuemmer T."/>
<person name="Bennett K.L."/>
<person name="Superti-Furga G."/>
<person name="Colinge J."/>
</authorList>
<dbReference type="PubMed" id="21269460"/>
<dbReference type="DOI" id="10.1186/1752-0509-5-17"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="26">
<citation type="journal article" date="2011" name="Sci. Signal." volume="4" first="RS3" last="RS3">
<title>System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation.</title>
<authorList>
<person name="Rigbolt K.T."/>
<person name="Prokhorova T.A."/>
<person name="Akimov V."/>
<person name="Henningsen J."/>
<person name="Johansen P.T."/>
<person name="Kratchmarova I."/>
<person name="Kassem M."/>
<person name="Mann M."/>
<person name="Olsen J.V."/>
<person name="Blagoev B."/>
</authorList>
<dbReference type="PubMed" id="21406692"/>
<dbReference type="DOI" id="10.1126/scisignal.2001570"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-252</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="27">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
<title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
<authorList>
<person name="Zhou H."/>
<person name="Di Palma S."/>
<person name="Preisinger C."/>
<person name="Peng M."/>
<person name="Polat A.N."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="23186163"/>
<dbReference type="DOI" id="10.1021/pr300630k"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Erythroleukemia</tissue>
</source>
</reference>
<reference key="28">
<citation type="journal article" date="2017" name="Mol. Cell" volume="67" first="387" last="399">
<title>HEXIM1 and NEAT1 Long non-coding RNA form a multi-subunit complex that regulates DNA-mediated innate immune response.</title>
<authorList>
<person name="Morchikh M."/>
<person name="Cribier A."/>
<person name="Raffel R."/>
<person name="Amraoui S."/>
<person name="Cau J."/>
<person name="Severac D."/>
<person name="Dubois E."/>
<person name="Schwartz O."/>
<person name="Bennasser Y."/>
<person name="Benkirane M."/>
</authorList>
<dbReference type="PubMed" id="28712728"/>
<dbReference type="DOI" id="10.1016/j.molcel.2017.06.020"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>INTERACTION WITH PRKDC; XRCC5; XRCC6; SFPQ; NONO; PSPC1; RBM14 AND MATR3</scope>
</reference>
<reference key="29">
<citation type="journal article" date="2007" name="Proc. Natl. Acad. Sci. U.S.A." volume="104" first="14312" last="14317">
<title>Structure of the Cyclin T binding domain of Hexim1 and molecular basis for its recognition of P-TEFb.</title>
<authorList>
<person name="Dames S.A."/>
<person name="Schoenichen A."/>
<person name="Schulte A."/>
<person name="Barboric M."/>
<person name="Peterlin B.M."/>
<person name="Grzesiek S."/>
<person name="Geyer M."/>
</authorList>
<dbReference type="PubMed" id="17724342"/>
<dbReference type="DOI" id="10.1073/pnas.0701848104"/>
</citation>
<scope>STRUCTURE BY NMR OF 255-359</scope>
<scope>SUBUNIT</scope>
<scope>INTERACTION WITH CCNT1</scope>
</reference>
<comment type="function">
<text evidence="8 9 11 13 14 16 17 21 27">Transcriptional regulator which functions as a general RNA polymerase II transcription inhibitor (PubMed:14580347, PubMed:15713661, PubMed:15201869). Core component of the 7SK RNP complex: in cooperation with 7SK snRNA sequesters P-TEFb in a large inactive 7SK snRNP complex preventing RNA polymerase II phosphorylation and subsequent transcriptional elongation (PubMed:12832472, PubMed:14580347, PubMed:15713661, PubMed:15201869). May also regulate NF-kappa-B, ESR1, NR3C1 and CIITA-dependent transcriptional activity (PubMed:15940264, PubMed:15941832, PubMed:17088550). Plays a role in the regulation of DNA virus-mediated innate immune response by assembling into the HDP-RNP complex, a complex that serves as a platform for IRF3 phosphorylation and subsequent innate immune response activation through the cGAS-STING pathway (PubMed:28712728).</text>
</comment>
<comment type="subunit">
<text evidence="8 9 12 13 14 15 16 17 18 19 20 23 24 25 26 27">Homooligomer and heterooligomer with HEXIM2; probably dimeric (PubMed:15713661, PubMed:15965233, PubMed:16377779). Core component of the 7SK RNP complex, at least composed of 7SK RNA, LARP7, MEPCE, HEXIM1 (or HEXIM2) and P-TEFb (composed of CDK9 and CCNT1/cyclin-T1) (PubMed:12832472, PubMed:15201869, PubMed:15169877, PubMed:16362050, PubMed:15713661, PubMed:15855166, PubMed:16377779, PubMed:17643375, PubMed:17724342). Interacts with the N-CoR complex through NCOR1 (PubMed:17452463). Interacts with ESR1 and NR3C1 (PubMed:15940264, PubMed:15941832). May interact with NF-kappa-B through RELA (PubMed:12581153). Interacts with CCNT2; mediates formation of a tripartite complex with KPNA2 (PubMed:19883659). Part of the HDP-RNP complex composed of at least HEXIM1, PRKDC, XRCC5, XRCC6, paraspeckle proteins (SFPQ, NONO, PSPC1, RBM14, and MATR3) and NEAT1 non-coding RNA (PubMed:28712728).</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-2832510">
<id>O94992</id>
</interactant>
<interactant intactId="EBI-2479671">
<id>O60563</id>
<label>CCNT1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>10</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-2832510">
<id>O94992</id>
</interactant>
<interactant intactId="EBI-1383449">
<id>P50750</id>
<label>CDK9</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>10</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-2832510">
<id>O94992</id>
</interactant>
<interactant intactId="EBI-2832510">
<id>O94992</id>
<label>HEXIM1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-2832510">
<id>O94992</id>
</interactant>
<interactant intactId="EBI-5460660">
<id>Q96MH2</id>
<label>HEXIM2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-2832510">
<id>O94992</id>
</interactant>
<interactant intactId="EBI-2371923">
<id>Q4G0J3</id>
<label>LARP7</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>10</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-2832510">
<id>O94992</id>
</interactant>
<interactant intactId="EBI-706637">
<id>Q15554</id>
<label>TERF2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="8 9 10 19 22">Nucleus</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="8 22">Cytoplasm</location>
</subcellularLocation>
<text>Binds alpha-importin and is mostly nuclear (PubMed:16362050).</text>
</comment>
<comment type="tissue specificity">
<text evidence="10 14">Ubiquitously expressed with higher expression in placenta. HEXIM1 and HEXIM2 are differentially expressed. Expressed in endocrine tissues.</text>
</comment>
<comment type="induction">
<text evidence="8 10 14">Up-regulated by HMBA (hexamethylene bisacetamide) (at protein level). Down-regulated by estrogen.</text>
</comment>
<comment type="domain">
<text>The coiled-coil domain mediates oligomerization.</text>
</comment>
<comment type="miscellaneous">
<text>Inhibits Tat activity which is required for HIV-1 transcription.</text>
</comment>
<comment type="similarity">
<text evidence="28">Belongs to the HEXIM family.</text>
</comment>
<dbReference type="EMBL" id="AB021179">
<property type="protein sequence ID" value="BAA36166.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK313557">
<property type="protein sequence ID" value="BAG36332.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC006460">
<property type="protein sequence ID" value="AAH06460.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS11495.1"/>
<dbReference type="RefSeq" id="NP_006451.1">
<property type="nucleotide sequence ID" value="NM_006460.2"/>
</dbReference>
<dbReference type="PDB" id="2GD7">
<property type="method" value="NMR"/>
<property type="chains" value="A/B=255-359"/>
</dbReference>
<dbReference type="PDB" id="3S9G">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.10"/>
<property type="chains" value="A/B=255-359"/>
</dbReference>
<dbReference type="PDBsum" id="2GD7"/>
<dbReference type="PDBsum" id="3S9G"/>
<dbReference type="BMRB" id="O94992"/>
<dbReference type="SMR" id="O94992"/>
<dbReference type="BioGRID" id="115860">
<property type="interactions" value="866"/>
</dbReference>
<dbReference type="CORUM" id="O94992"/>
<dbReference type="DIP" id="DIP-46463N"/>
<dbReference type="IntAct" id="O94992">
<property type="interactions" value="33"/>
</dbReference>
<dbReference type="MINT" id="O94992"/>
<dbReference type="STRING" id="9606.ENSP00000328773"/>
<dbReference type="ChEMBL" id="CHEMBL3120044"/>
<dbReference type="iPTMnet" id="O94992"/>
<dbReference type="PhosphoSitePlus" id="O94992"/>
<dbReference type="BioMuta" id="HEXIM1"/>
<dbReference type="EPD" id="O94992"/>
<dbReference type="jPOST" id="O94992"/>
<dbReference type="MassIVE" id="O94992"/>
<dbReference type="MaxQB" id="O94992"/>
<dbReference type="PaxDb" id="O94992"/>
<dbReference type="PeptideAtlas" id="O94992"/>
<dbReference type="PRIDE" id="O94992"/>
<dbReference type="ProteomicsDB" id="50620"/>
<dbReference type="Antibodypedia" id="1837">
<property type="antibodies" value="437 antibodies"/>
</dbReference>
<dbReference type="DNASU" id="10614"/>
<dbReference type="Ensembl" id="ENST00000332499">
<property type="protein sequence ID" value="ENSP00000328773"/>
<property type="gene ID" value="ENSG00000186834"/>
</dbReference>
<dbReference type="GeneID" id="10614"/>
<dbReference type="KEGG" id="hsa:10614"/>
<dbReference type="UCSC" id="uc002iig.4">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="10614"/>
<dbReference type="DisGeNET" id="10614"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000186834.3"/>
<dbReference type="GeneCards" id="HEXIM1"/>
<dbReference type="HGNC" id="HGNC:24953">
<property type="gene designation" value="HEXIM1"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000186834">
<property type="expression patterns" value="Low tissue specificity"/>
</dbReference>
<dbReference type="MIM" id="607328">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_O94992"/>
<dbReference type="OpenTargets" id="ENSG00000186834"/>
<dbReference type="PharmGKB" id="PA142671694"/>
<dbReference type="eggNOG" id="ENOG502QQP8">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00390000002808"/>
<dbReference type="HOGENOM" id="CLU_066028_0_0_1"/>
<dbReference type="InParanoid" id="O94992"/>
<dbReference type="KO" id="K15189"/>
<dbReference type="OMA" id="VHEERNP"/>
<dbReference type="OrthoDB" id="1055089at2759"/>
<dbReference type="PhylomeDB" id="O94992"/>
<dbReference type="TreeFam" id="TF336851"/>
<dbReference type="PathwayCommons" id="O94992"/>
<dbReference type="SIGNOR" id="O94992"/>
<dbReference type="BioGRID-ORCS" id="10614">
<property type="hits" value="85 hits in 875 CRISPR screens"/>
</dbReference>
<dbReference type="ChiTaRS" id="HEXIM1">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="O94992"/>
<dbReference type="GeneWiki" id="HEXIM1"/>
<dbReference type="GenomeRNAi" id="10614"/>
<dbReference type="Pharos" id="O94992">
<property type="development level" value="Tbio"/>
</dbReference>
<dbReference type="PRO" id="PR:O94992"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 17"/>
</dbReference>
<dbReference type="RNAct" id="O94992">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000186834">
<property type="expression patterns" value="Expressed in placenta and 240 other tissues"/>
</dbReference>
<dbReference type="Genevisible" id="O94992">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0005737">
<property type="term" value="C:cytoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HGNC-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0043231">
<property type="term" value="C:intracellular membrane-bounded organelle"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0005654">
<property type="term" value="C:nucleoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0097322">
<property type="term" value="F:7SK snRNA binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0004861">
<property type="term" value="F:cyclin-dependent protein serine/threonine kinase inhibitor activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HGNC-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0042802">
<property type="term" value="F:identical protein binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="IntAct"/>
</dbReference>
<dbReference type="GO" id="GO:0017069">
<property type="term" value="F:snRNA binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HGNC-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0002218">
<property type="term" value="P:activation of innate immune response"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0007507">
<property type="term" value="P:heart development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0045087">
<property type="term" value="P:innate immune response"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0045736">
<property type="term" value="P:negative regulation of cyclin-dependent protein serine/threonine kinase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HGNC-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0000122">
<property type="term" value="P:negative regulation of transcription by RNA polymerase II"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HGNC-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0045892">
<property type="term" value="P:negative regulation of transcription, DNA-templated"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HGNC-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:1901798">
<property type="term" value="P:positive regulation of signal transduction by p53 class mediator"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="CACAO"/>
</dbReference>
<dbReference type="InterPro" id="IPR024872">
<property type="entry name" value="HEXIM"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR13469">
<property type="entry name" value="PTHR13469"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF15313">
<property type="entry name" value="HEXIM"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PRINTS" id="PR02094">
<property type="entry name" value="HEXIMFAMILY"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0175">Coiled coil</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0391">Immunity</keyword>
<keyword id="KW-0399">Innate immunity</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0678">Repressor</keyword>
<keyword id="KW-0804">Transcription</keyword>
<keyword id="KW-0805">Transcription regulation</keyword>
<feature type="chain" description="Protein HEXIM1" id="PRO_0000305263">
<location>
<begin position="1"/>
<end position="359"/>
</location>
</feature>
<feature type="region of interest" description="Basic region; mediates nuclear localization and interaction with 7SK snRNA and NR3C1" evidence="17">
<location>
<begin position="150"/>
<end position="177"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with P-TEFb">
<location>
<begin position="202"/>
<end position="205"/>
</location>
</feature>
<feature type="region of interest" description="Autoinhibitory acidic region; in absence of 7SK snRNA interacts with the basic region preventing interaction with P-TEFb and modulating subcellular localization">
<location>
<begin position="210"/>
<end position="250"/>
</location>
</feature>
<feature type="region of interest" description="Mediates interaction with CCNT1">
<location>
<begin position="286"/>
<end position="314"/>
</location>
</feature>
<feature type="region of interest" description="Required for inhibition of ESR1-dependent transcription">
<location>
<begin position="310"/>
<end position="355"/>
</location>
</feature>
<feature type="coiled-coil region" evidence="7">
<location>
<begin position="283"/>
<end position="349"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="2">
<location>
<position position="97"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="2">
<location>
<position position="98"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="2 3 4">
<location>
<position position="233"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="2 3 4">
<location>
<position position="236"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="2 3 4">
<location>
<position position="237"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="2 3 4 5">
<location>
<position position="252"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="6">
<location>
<position position="260"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes interaction with 7SK snRNA." evidence="13">
<original>KHRR</original>
<variation>ILAA</variation>
<location>
<begin position="152"/>
<end position="155"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes interaction with 7SK snRNA." evidence="19">
<original>RRR</original>
<variation>AAA</variation>
<location>
<begin position="154"/>
<end position="156"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes interaction with P-TEFb; when associated with D-205." evidence="13">
<original>Y</original>
<variation>D</variation>
<location>
<position position="203"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes interaction with P-TEFb. Same effect; when associated with D-203." evidence="13">
<original>T</original>
<variation>D</variation>
<location>
<position position="205"/>
</location>
</feature>
<feature type="mutagenesis site" description="Partial loss of function." evidence="18">
<original>F</original>
<variation>A</variation>
<variation>D</variation>
<variation>K</variation>
<location>
<position position="208"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of function." evidence="18">
<original>Y</original>
<variation>A</variation>
<variation>E</variation>
<location>
<position position="271"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of oligomerization; when associated with A-294; A-332 and A-339. Loss of function and interaction with P-TEFb; when associated with A-294." evidence="20">
<original>L</original>
<variation>A</variation>
<location>
<position position="287"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of oligomerization; when associated with A-287; A-332 and A-339. Loss of function and interaction with P-TEFb; when associated with A-287." evidence="20">
<original>L</original>
<variation>A</variation>
<location>
<position position="294"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of oligomerization; when associated with A-287; A-294 and A-339." evidence="20">
<original>L</original>
<variation>A</variation>
<location>
<position position="332"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of oligomerization; when associated with A-287; A-294 and A-332." evidence="20">
<original>L</original>
<variation>A</variation>
<location>
<position position="339"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="268"/>
<end position="280"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="284"/>
<end position="315"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="319"/>
<end position="348"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3S9G"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18669648"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19690332"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="20068231"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="21406692"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q8R409"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000255"/>
<evidence key="8" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12581153"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12832472"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12941847"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14580347"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15169877"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15201869"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15713661"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15855166"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15940264"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15941832"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15965233"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16362050"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16377779"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17088550"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17395637"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17452463"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17643375"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17724342"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19883659"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="28712728"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000305"/>
<sequence length="359" mass="40623" checksum="B12845C4E2595FF0" modified="1999-05-01" version="1">MAEPFLSEYQHQPQTSNCTGAAAVQEELNPERPPGAEERVPEEDSRWQSRAFPQLGGRPGPEGEGSLESQPPPLQTQACPESSCLREGEKGQNGDDSSAGGDFPPPAEVEPTPEAELLAQPCHDSEASKLGAPAAGGEEEWGQQQRQLGKKKHRRRPSKKKRHWKPYYKLTWEEKKKFDEKQSLRASRIRAEMFAKGQPVAPYNTTQFLMDDHDQEEPDLKTGLYSKRAAAKSDDTSDDDFMEEGGEEDGGSDGMGGDGSEFLQRDFSETYERYHTESLQNMSKQELIKEYLELEKCLSRMEDENNRLRLESKRLGGDDARVRELELELDRLRAENLQLLTENELHRQQERAPLSKFGD</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>

